Hypergammaglobulinemia pathophysiology

Jump to navigation Jump to search

Hypergammaglobulinemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypergammaglobulinemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypergammaglobulinemia pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hypergammaglobulinemia pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypergammaglobulinemia pathophysiology

CDC on Hypergammaglobulinemia pathophysiology

Hypergammaglobulinemia pathophysiology in the news

Blogs on Hypergammaglobulinemia pathophysiology

Directions to Hospitals Treating Hypergammaglobulinemia

Risk calculators and risk factors for Hypergammaglobulinemia pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Soujanya Thummathati, MBBS [2]

Overview

Hypergammaglobulinemia is an immunoproliferative disorder with elevated levels of gamma globulin (immunoglobulins or antibodies).[1][2]

Pathophysiology

  • Hypergammaglobulinemia is an immunoproliferative disorder which arises from B cells, which are a type of white cells that are normally involved in the development of humoral immunity by secreting antibodies.[3]
  • The majority of the hypergammaglobulinemias are caused by an excess of immunoglobulin M (IgM) because this is the default immunoglobulin type prior to class switching.[1]
  • Hypergammaglobulinemias may also be caused by a deficiency in the other major types of immunoglobulins.[1][4]
  • The term "hypergammaglobulinemia" refers to the position of the excess of proteins after serum protein electrophoresis (found in the gammaglobulin region).[1]
  • CD40 ligand is also important for other functions carried out by T-lymphocytes, so patients with X-linked hyper IgM syndrome (XHIM) have defective cellular immunity and are also susceptible to all kinds of infections, particularly opportunistic infections and to some types of cancer

Normal Mechanism of Immunoglobulin Class Switching

  • Immunoglobulin class switching, also known as isotype switching, isotypic commutation or class-switch recombination (CSR), is a biological mechanism that changes a B cell's production of immunoglobulins (antibodies) from one type to another, such as from the isotype IgM to the isotype IgG.
  • Naïve mature B cells produce both IgM and IgD, which are the first two heavy chain segments in the immunoglobulin locus.
    • After activation by the antigen, the B cells proliferate. If these activated B cells encounter specific signaling molecules via their CD40 and cytokine receptors (both modulated by T helper cells), they undergo antibody class switching to produce IgG, IgA or IgE antibodies.
    • During class switching, the constant region of the immunoglobulin heavy chain changes but the variable regions, and therefore antigenic specificity, stay the same. This allows different daughter cells from the same activated B cell to produce antibodies of different isotypes or subtypes (e.g. IgG1 and IgG2).[5]
  • Class switching occurs by a mechanism called class switch recombination (CSR) binding.
    • During CSR, portions of the antibody heavy chain locus are removed from the chromosome, and the gene segments surrounding the deleted portion are rejoined to retain a functional antibody gene that produces antibody of a different isotype.
    • Double-stranded breaks are generated in DNA at conserved nucleotide motifs, called switch (S) regions, which are upstream from gene segments that encode the constant regions of antibody heavy chains.
    • DNA is nicked and broken at two selected S-regions by the activity of a series of enzymes, including Activation-Induced (Cytidine) Deaminase (AID), uracil DNA glycosylase and apyrimidic/apurinic (AP)-endonucleases.[6][5]= 11 | pages= 1101-3 | pmid=15496946 | doi=10.1038/ni1104-1101 | pmc=PMC4625794 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15496946 }} </ref>
    • The intervening DNA between the S-regions is subsequently deleted from the chromosome, removing unwanted μ or δ heavy chain constant region exons and allowing substitution of a γ, α or ε constant region gene segment.
    • The free ends of the DNA are rejoined by a process called non-homologous end joining (NHEJ) to link the variable domain exon to the desired downstream constant domain exon of the antibody heavy chain.[7]
    • In the absence of non-homologous end joining, free ends of DNA may be rejoined by an alternative pathway biased toward microhomology joins.[8]

Type 1 hypergammaglobulinemia

  • The tumor necrosis factor super family member 5 (TNFSF5) gene mutation is involved in the pathogenesis of type 1 hypergammaglobulinemia.
  • Type 1 hypergammaglobulinemia is transmitted in x-linked recessive pattern and is the most common type of hypergammaglobulinemia.

mutation in the Tumor Necrosis Factor Super Family member 5 (TNFSF5) gene, which codes for CD40 ligand

References

  1. 1.0 1.1 1.2 1.3 Hypergammaglobulinemia. Wikipedia. https://en.wikipedia.org/wiki/Hypergammaglobulinemia Accessed on February 24, 2016.
  2. Globulin. Wikipedia. https://en.wikipedia.org/wiki/Globulin. Wikipedia. Accessed on February 24, 2016.
  3. B cell. Wikipedia. https://en.wikipedia.org/wiki/B_cell Accessed on February 24, 2016.
  4. Immunoproliferative disorder. Wikipedia. Accessed on February 24, 2016.
  5. 5.0 5.1 Durandy A (2003). "Activation-induced cytidine deaminase: a dual role in class-switch recombination and somatic hypermutation". Eur J Immunol. 33 (8): 2069–73. doi:10.1002/eji.200324133. PMID 12884279.
  6. Casali P, Zan H (2004). "Class switching and Myc translocation: how does DNA break?". Nat Immunol. 5 (11): 1101–3. doi:10.1038/ni1104-1101. PMC 4625794. PMID 15496946.
  7. Lieber MR, Yu K, Raghavan SC (2006). "Roles of nonhomologous DNA end joining, V(D)J recombination, and class switch recombination in chromosomal translocations". DNA Repair (Amst). 5 (9–10): 1234–45. doi:10.1016/j.dnarep.2006.05.013. PMID 16793349.
  8. Yan CT, Boboila C, Souza EK, Franco S, Hickernell TR, Murphy M; et al. (2007). "IgH class switching and translocations use a robust non-classical end-joining pathway". Nature. 449 (7161): 478–82. doi:10.1038/nature06020. PMID 17713479.
  9. Immunoglobulin class switching. Wikipedia. https://en.wikipedia.org/wiki/Immunoglobulin_class_switching. AccessedonFebruary 29, 2016.

Related Chapters

Template:WikiDoc Sources